The Assistant Secretary for Preparedness and Response must come up with a list of approximately 26 drugs, secure a six-month supply, and prioritize domestic sourcing.
The industry’s robotics market showed the strongest sector growth in the second quarter of 2025, according to new data from the Association for Advancing Automation.
While the agency’s PreCheck regulatory framework is a good first step, it remains to be seen whether the program boosts U.S. drug manufacturing, says former FDA official.
The contract manufacturer has 11 late-stage projects with commercial approval potential within the next few years, including a developer of GLP-1 therapeutics for obesity.
The Garden State, called the “medicine chest” to the world, continues to show robust activity with life sciences firms accounting for nearly 30% of all Q2 leasing activity.
President Trump told CNBC his administration would initially levy a “small” pharma-specific tariff, followed by an increase to 150% in a year or so and then as high as 250%.
While the facility has had several run-ins in recent years with U.S. regulators, selling the site is part of Lilly’s broader global manufacturing strategy.
The Waltham, Massachusetts facility met nine system criteria under the Initiative for Certification of Manufacturing Capabilities program, the company said.
The investment is part of the drugmaker’s previously announced plan to invest more than $10 billion in its U.S. manufacturing operations over the next 10 years.
Discover how automated calibration improves compliance, reduces human error, and increases efficiency in pharmaceutical manufacturing. This Beamex white paper explores the benefits...
Unlock the full potential of your GMP assets. Discover how life sciences organizations can optimize reliability, compliance, and performance with a data-driven approach to Asset...
Three of Cognite's chemical, refining, and energy customers take center stage in this product tour video that showcases why and how they are transforming their operations.
Are you making quick-enough progress on your industrial Gen AI journey? Learn what it actually takes to trust, deliver, and scale across operational use cases.
